S troke is a major health burden and the leading cause of serious long-term disability around the world. 1, 2 One of the most cumbersome deficits after unilateral stroke is impairment in the contralateral upper limb, typically seen in approximately 70% of the stroke population. 3, 4 Despite studies reporting on motor and functional recovery of the upper limb, 5,6 information on the contribution of somatosensory deficits toward motor and functional outcome is scant.
The term somatosensation refers to a sensation arising from the skin, muscles, or joints. Somatosensation is distinct from interoceptive or visceral sensation and special senses such as sight, hearing, smell, and taste. Within the somatosensory system, different modalities such as light touch, proprioception, and stereognosis are identified. 7 Somatosensory deficits of these modalities appear to be common after stroke, with prevalence rates ranging from 11% to 85%. 8 Variability is thought to be related to differences in definition, somatosensory modalities tested, and assessment method used. 8 Most health care professionals consider somatosensory testing an essential part of the clinical assessment process and a valuable method of obtaining information for diagnosis and prognosis of functional ability. 9 Somatosensory impairment also is often a concern of the patient, emphasizing the need to accurately monitor somatosensory impairments with reliable assessment methods to gain further insight into the extent of these deficits after stroke.
An extensive body of animal literature suggests that the projection from the somatosensory cortex to the motor cortex is important in the acquisition of new motor skills. 10, 11 Activation of the sensory cortex has been linked to excitation of the motor human cortex as well. 12 The work of Vidoni and Boyd 13 showed that stroke-related somatosensory deficits are associated with disrupted motor learning. They demonstrated that proprioceptive integrity was strongly related to the magnitude of behavioral change associated with learning a repeated tracking task. Furthermore, repetitive peripheral nerve sensory stimulation has been shown to facilitate motor performance. 14 Several studies investigated the impact of somatosensory deficits on outcome after stroke. Impaired somatosensory function has been related to a longer hospital length of stay and dependency in activities of daily living (ADLs). 15, 16 Previous studies 17, 18 showed that patients with well-preserved somatosensation achieve a greater improvement in upper limb motor function and are more likely to reach independence in self-care function compared with patients with somatosensory deficiencies. Also, in 2 systematic reviews, 19,20 some of the included studies suggested somatosensory loss to contribute as an independent predictor of upper limb motor and functional recovery. However, these reviews were conducted to summarize potential predictors of upper limb recovery after stroke. Therefore, the focus of these reviews was not on the predictive value of somatosensory impairments, as the clinical somatosensory variables were studied only as co-factors. Also, only longitudinal recovery studies were included in these reviews, and the psychometric properties of the predictor variables and outcome measures were not considered. So far, there is a range of diverse studies with different study designs, all using different measures of somatosensation, both clinical and neurophysiological measures, to determine the impact on various outcome measures after stroke. This variability makes it difficult to draw rigorous conclusions. There is need for a better understanding of the role of different modalities of somatosensation in outcome after stroke.
To our knowledge, there has been no systematic overview of the association between somatosensory impairments in the upper limb and outcome after stroke. This information would be useful to identify appropriate interventions because treatment of somatosensory impairment may positively influence motor output. 8 Therefore, the aim of this study was to systematically review the current, available literature regarding the association of somatosensory impairments in the upper limb with outcome after stroke.
Method Data Sources and Searches
We carried out a systematic review on the association between somatosensory impairments in the arm and hand and upper limb impairment, activity, and participation measures after stroke. Guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement for reporting systematic reviews 21 were followed. Articles were identified by searching the following electronic databases: tion, and prediction, as well as their synonyms and plurals, were included. The Appendix shows the search strategy used for EMBASE, which was adapted for the other electronic databases. In addition, reference lists from the included articles were hand searched to detect further relevant articles.
Study Selection
The inclusion and exclusion criteria for article selection were as follows. Adult participants with a diagnosis of stroke were considered. We included patients with both hemorrhagic and ischemic stroke. Articles were selected for inclusion if the study included at least 10 participants, as determination of clinical prediction rules requires a minimum of 10 participants per prognostic variable investigated. 22 As proposed by Connell and Tyson, 23 independent variables of interest were reliable and valid clinical measures of somatosensory function in the upper limb, such as measures of touch, position sense, stereognosis, and so on. Studies using neurophysiological measures of somatosensation (ie, somatosensory evoked potentials [SSEPs]) also were included. Following the International Classification of Functioning, Disability and Health (ICF) model, 24 outcomes of primary interest comprised standardized measures of impairment, activity, and participation of the upper limb. Only those studies with a correlational analysis or integration of the measure of somatosensation in a predictive regression model were included. Articles needed to be written in English, Dutch, Finnish, or Swedish. We excluded articles that had mixed etiology groups if data for participants with stroke could not be extracted. Studies using measures of somatosensation involving an overall score for both upper limb and lower limb outcome, as well as those including only lower limb outcome measures, also were excluded.
Data Extraction and Quality Assessment
After removal of duplicates, eligibility assessment was performed by 2 independent reviewers (S.M. and A.H.K.) by screening titles and abstracts. This assessment was subsequently followed by the assessment of the full text of articles. In case of disagreement, consensus was reached through discussion. A specifically developed data extraction sheet was used during the full-text screening. Information was collected about study design (crosssectional or longitudinal), study setting, time points of follow-up assessments, participant details, inclusion and exclusion criteria, independent variables, outcome variables, statistical analysis, and results on the association between the measure of somatosensation and the outcome. When crucial information was missing, the author of the article was contacted.
The selected studies in the review were subjected to a methodological quality assessment according to the validated Downs and Black quality scale, 25 which was modified to suit the observational study designs of the studies. Due to the lack of a gold standard for assessing quality of observational studies, the Downs and Black quality scale was used, as this scale was recommended in a systematic review 26 of instruments for assessing quality of observational studies (albeit with recognized limitations). Furthermore, the Cochrane Collaboration 27 recommends the same instrument for assessing quality in nonrandomized studies. Therefore, we used the Downs and Black scale. Eight questions of this quality appraisal instrument (questions 4, 8, 14, 15, 19, 23, 24, and 27), therefore, were not applicable due to the nature of the observational study designs included in this review. Additionally, 2 other items (questions 9 and 26) were not applicable for studies with a cross-sectional design. Therefore, when all remaining items were positively appraised, total scores of 20 and 18 points could be assigned to studies with a longitudinal design and a crosssectional design, respectively. Finally, the total scores were transformed to a percentage. Although no cutoff score is available for the Downs and Black quality scale to identify high-quality studies, a previous study 28 using a similar quality scale showed that studies should have a score of at least 65% of the maximum possible score to be classified as having substantial quality. Therefore, a cutoff score of Ն65% was used for inclusion in this review. Both data extraction and quality evaluation checklists were completed by 2 independent reviewers (S.M. and A.H.K.), and, in case of disagreement, consensus was reached through discussion.
Data Synthesis and Analysis
The heterogeneity among studies with regard to the population, somatosensory, and outcome variables used precluded a pooling of results in a formal meta-analysis. Therefore, a descriptive review of the results of the included studies is reported, according to the different outcome measures within the domains of the ICF model. 24 Within each domain, results are presented according to the somatosensory modalities that were measured.
Results

Characteristics of the Included Studies
Our search identified a total of 3,440 hits. A flowchart of the selection process is shown in the Figure. The process yielded a total of 6 articles 29 -34 for inclusion in this systematic review.
The main characteristics of the included articles, such as patient characteristics and the somatosensory and Somatosensory Deficits in the Arm and Hand After Stroke outcome measures used, are shown in the eTable (available at ptjournal. apta.org). Five articles 29 -31,33,34 had a longitudinal design, and 1 article 32 had a cross-sectional design. Cumulatively, these 6 articles involved 694 adult participants with stroke. The sample size reported within the included articles ranged from 64 31 to 222 34 at baseline, and half of the studies 30, 33, 34 had an initial sample size of more than 100 participants. Three articles 29, 31, 33 included patients in the early phase after stroke, ranging from the first week 29 to 1 month 31 after stroke, whereas 1 article 32 focused on patients in the chronic phase (ie, more than 6 months after stroke). With regard to the type of stroke, 58% of the patients were classified with infarction, 6% were classified with hemorrhage, and for 36% of the patients, the pathology was unavailable. In the longitudinal studies reporting loss to fol- 
Figure.
Flowchart showing how studies were derived. Gray literature searching encompasses searching the reference lists of articles already eligible for inclusion.
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low-up, 29 -31,33 the percentage of participants lost to follow-up varied between 12% 33 and 23%. 30 A wide range of somatosensory variables, including neurophysiological and clinical somatosensory measures, was reported on. The search process identified 1 study 31 that measured SSEPs over the trajectory of the median nerve at the wrist. Furthermore, the Fugl-Meyer sensory assessment of the upper limb, assessing light touch and proprioception, was used in 3 studies. 30, 33, 34 This valid and reliable test is used extensively in stroke studies. 35 Investigating light touch by using Semmes-Weinstein monofilaments was described in 1 study. 29 Intraclass correlation coefficients greater than .90 were reported for both interrater and intrarater reliability. 29 Two-point discrimination 29 and the revised Nottingham Sensory Assessment (NSA) 32 were similarly only tested occasionally, both being reliable assessment methods 29, 36 for somatosensory functioning. None of the studies combined SSEPs and a clinical somatosensory measure to evaluate the prognostic information of both type of measures.
Six different outcome measures were identified in the included studies. Of these, according to the classification proposed by Connell and Tyson, 37 3 outcome measures assessed upper limb impairments: the Fugl-Meyer motor assessment, 31, 33 shoulder pain, 33 and the Action Research Arm Test (ARAT). 29 Only 1 measure of activity limitations was used in the included studies: the Motor Activity Log. 34 Additionally, 2 articles reported outcomes at the participation level. 30, 32 The included studies also used a wide range of follow-up periods, ranging from 1 month after discharge from the rehabilitation center 33 to approximately 2 years after stroke. 34 Most of the studies used fixed time points for measurements, such as 3 months, 29 6 months, 29, 31 or 12 months 31 after stroke. Multiple regression analysis was used in all 6 studies.
Results regarding the association between somatosensory deficits and outcome after stroke and an overview of the methodological quality assessment of the 6 included studies are shown in the Table. Body Function Light touch and proprioception (Fugl-Meyer sensory assessment). In the study by Paci et al, 33 a very small proportion of the variance in motor performance in the upper limb 1 month after admission to the rehabilitation center could be explained by the ability to feel light touch and proprioception in the upper limb (measured on admission to the rehabilitation center [R 2 ϭ.01]). The somatosensory variable was not retained as a predictive factor for shoulder pain at follow-up.
Somatosensory evoked potentials. In the study by Feys et al, 31 SSEPs, measured on admission to the rehabilitation center, were shown to have predictive value in upper limb motor outcome at 6 and 12 months after stroke. The somatosensory impairment accounted for 8% in the explained variance of upper limb motor outcome.
Two-point
discrimination. Au-Yeung 29 found significant odds ratios of 0.51 to 0.83 for the relationship between 2-point discrimination, measured at the first 3 weeks after stroke and an outcome of more than 35 points on the ARAT at 3 and 6 months after stroke. This finding indicates that patients who are able to discriminate between 2 points at the distal pulp of their index finger in the acute phase after stroke have a greater chance of achieving dexterity at 3 and 6 months after stroke.
Pressure perception. The level of pressure perception, as measured with monofilaments, was not retained as a predictive factor for recovery of dexterity in the study by Au-Yeung. 29 Activity Light touch and proprioception (Fugl-Meyer sensory assessment). In the study by Park et al, 34 a significant odds ratio of 0.2 for the relationship between proprioception measured with the Fugl-Meyer sensory assessment at 3 to 9 months after stroke and the quality of movement subscale of the Motor Activity Log 12 months later was demonstrated. A statistically nonsignificant relationship was found for the light touch subscale of the Fugl-Meyer sensory assessment.
Participation
Light touch and proprioception (Fugl-Meyer sensory assessment). Desrosiers et al 30 found a low but significant univariate correlation (rϭ.24) between the Fugl-Meyer sensory assessment assessing light touch and proprioception at discharge from the rehabilitation center and the handicap situations during ADLs and social roles, as assessed with the Assessment of Life Habits questionnaire 6 months later.
Tactile sensation, proprioception, and stereognosis (revised Nottingham Sensory Assessment).
In a cross-sectional study in the chronic phase after stroke by Morris et al, 32 a low but significant negative correlation (rϭϪ.17, rϭϪ.25) was only found between proprioceptive dysfunction and the perceived physical activity subscale and social isolation subscale of the Nottingham Health Profile. The somatosensory variable could not be retained in the multiple regression analysis. 
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Discussion
It was the aim of this study to systematically review and summarize the current, available literature regarding the association of somatosensory impairments in the upper limb with outcome after stroke. We identified a total of 6 high-quality studies that reported on the influence of somatosensory impairments in the upper limb on impairments in body function, activity, and participation after stroke. These studies showed that 2-point discrimination is a good predictor for upper limb dexterity and that SSEPs have predictive value in upper limb motor recovery. Additionally, proprioception was shown to be significantly correlated with the perceived level of physical activity and social isolation and had some predictive value for the quality of functional movements in the upper limb. Finally, the combination of light touch and proprioception impairment was shown to be significantly related to both upper limb motor recovery and handicap situations during ADLs and social roles. In 4 out of 6 studies, the somatosensory variable could be retained as independent predictor, but with rather low scores in explained variances.
Coupar et al 19 systematically reviewed the literature on potential predictors of upper limb motor and functional recovery after stroke. The authors also found evidence for the association between the presence of SSEPs and better upper limb recovery, but they found inconclusive evidence for an association between clinical somatosensory deficits and upper limb function. It is important to notice that our systematic review had a different emphasis. We included both cross-sectional and longitudinal studies to explore only the association of somatosensory deficits with different outcomes after stroke. Furthermore, we included only reliable and valid measures of somatosensation. This approach resulted in a clear difference in the number of studies included in both reviews. Coupar and colleagues 19 included 19 studies addressing somatosensory deficits after stroke. Our review included only 4 of these studies because of our methodologically rigorous inclusion and exclusion criteria. Additionally, we identified another 2 high-quality studies 30, 32 in order to give a more focused and comprehensive review on this topic.
Critical Considerations
Some limitations regarding the studies included in our review need to be addressed. First, it is important to note that almost 40% of the full-text articles we screened for eligibility were excluded based on the absence of psychometric data of the clinical somatosensory measure in the upper limb. This finding revealed the large number of nonstandardized measures of somatosensation used for research purposes, but probably also in the clinical setting. Unfortunately, all efforts invested when conducting these studies are nullified when assessments of unknown psychometric quality are used. Given these findings, it is remarkable that the Nottingham Sensory Assessment was used in only 1 of the included studies, although it was the recommended somatosensory outcome measure in a systematic review by Connell and Tyson 23 regarding outcome measures of somatosensation in neurological conditions. Furthermore, more objective somatosensory measures may have an additional predictive value. A relatively new, promising somatosensory measure is the perceptual threshold of touch, 38 in which high-frequency transcutaneous electrical nerve stimulation is used to activate cutaneous receptors of light touch and their A␤-fibers in order to determine the threshold of touch in an objective way. Further research is needed to determine the usefulness in clinical practice of this new technique and the predictive value on outcome after stroke. Additionally, robotic devices may help to detect proprioceptive disorders in a more standardized way. Arm position matching tasks with both arms positioned on an exoskeleton robotic device allow different variables to be tracked more accurately and provide reliable 2-or 3-dimensional quantifications of deficits in position sense. 39 Second, we noted a low proportion of participants included in the studies with an initial diagnosis of somatosensory impairments or only mild somatosensory deficits that were present in studies examining a cohort of people after stroke. Of particular interest is the contribution of somatosensory impairments in motor and functional outcomes in a study sample in which a large proportion of patients are encompassed with somatosensory impairments or patients experience more severe somatosensory impairment. These considerations could lead to different results regarding the contribution of somatosensory impairments in the explained variances of the outcome variable. Furthermore, none of the studies explored the lesion location and volume of the stroke. This would seem to be an important factor affecting somatosensation. In 3 of the 6 included studies, magnetic resonance imaging findings were studied as 1 of the other independent variables in the regression models. Only 1 study (Au-Yeung 29 ) demonstrated a significant correlation with outcome after stroke. None of the studies investigated the relationship between the location and extent of the lesion with somatosensory impairments.
Finally, we need to consider the methodological quality of the studies. Thirteen out of 19 studies eligible for inclusion had only poor to Somatosensory Deficits in the Arm and Hand After Stroke moderate quality (score Ͻ65% of the maximum score) and, therefore, were excluded from this review. This finding indicates that most of the studies (68%) in this research field are of insufficient rigor to allow meaningful conclusions; therefore, results need to be interpreted with caution. Although we acknowledge the difficult nature of carrying out this kind of study, new large, highquality cohort studies will be needed in the future.
An important consideration of our review relates to the heterogeneity of the included studies, which warrants caution when interpreting our results. Many different study designs, somatosensory variables, and outcome measures were used, and there was great variability in lengths of follow-up, data analysis, and presentation methods. Five of the included studies had a longitudinal design, which is crucial to assess the impact of somatosensory problems on recovery after stroke. However, based on previous literature, highquality cross-sectional studies also may provide valuable information. The cross-sectional study included in this review allows us to gain insights into the time-independent relationship between somatosensation and health-related quality of life at 6 months after stroke.
The heterogeneity of the included studies also prevented us from pooling data and drawing more detailed conclusions about the impact of different somatosensory modalities, such as light touch or proprioception, on upper limb motor and functional outcome after stroke. Bias in setting and study participants needs consideration when indirectly comparing results across studies. Furthermore, the question of whether neurophysiological measures have a higher predictive value compared with clinical somatosensory measures in outcome after stroke could not be answered due to the small number of high-quality studies using neurophysiological measures of somatosensation and the lack of studies combining both neurophysiological and clinical somatosensory measures in predicting motor outcome after stroke. Moreover, we expected to find stronger correlations in cross-sectional studies than in longitudinal studies. Conversely, we could not find any differences in results between cross-sectional and longitudinal studies, possibly due to the high heterogeneity of the included studies and the small amount of high-quality crosssectional studies. Another drawback is publication bias. Studies with significant results are more likely to be published. We addressed this limitation through a rigorous searching process in different databases. It is reassuring that our search identified studies similar to those in other recent reviews in this area.
Finally, it should be noted that the quality assessment criteria are also a concern with this type of review. Because of the lack of a gold standard for assessing quality of observational studies, we modified the methodological quality assessment of the Downs and Black quality scale. 25 This scale originally was designed to assess the methodological quality both of randomized and nonrandomized studies of health care interventions. Different questions of this quality appraisal instrument were not applicable due to the nature of the observational study designs included in this review. Through omitting 2 additional questions in the quality appraisal of crosssectional studies, we can guarantee that the quality assessment was not biased toward longitudinal studies and that there was no penalization of studies with a cross-sectional design. Important to note is the fact that some of the articles included for quality appraisal were published long before the concepts brought forward in the article by Downs and Black were ever published. This may be 1 factor explaining the low scores in the quality rating.
Implications for Practice
Recommendation for practice includes the use of reliable and valid measurement instruments. The importance of somatosensory testing as an essential part of the clinical assessment process is recognized by both patients and health care personnel, 9 emphasizing the need for accurate, reliable assessment methods. As pointed out above, a huge dropout of studies was attributed to the unpublished psychometric properties of the included measures of somatosensation. The recent publication proposed by Connell and Tyson 23 offers a guideline for using reliable, valid, and clinically useful measures of somatosensation. Although the measurement of all somatosensory modalities looks impracticable and difficult to justify in the clinical setting in patients with stroke, we do recommend 1 testing of each modality of somatosensation, such as light touch, pressure, pinprick, proprioception, discrimination tasks, and stereognosis. Furthermore, it is important to assess patients from the acute phase after stroke along the rehabilitation process to accurately monitor progress. Also, up to now, results from somatosensory assessments have not been routinely used to set goals for treatment programs. Treatment of somatosensory deficits is needed because it also may positively influence motor output. 8 A recent systematic review conducted by Doyle et al 7 examined interventions for somatosensory impairment in the upper limb after stroke and indicated insufficient evidence about the effects of treatment interventions. This finding was attributed to the large variety of Somatosensory Deficits in the Arm and Hand After Stroke interventions and the small number of included articles. Still, some of the studies included in the review of Doyle et al suggested preliminary evidence for the effects of some specific interventions, such as thermal stimulation and intermittent pneumatic compression for improving somatosensation after stroke. Another recent randomized controlled trial 40 provided evidence for improvement in functional sensory discrimination capacity after stroke when providing patients intensive sensory discrimination training based on perceptual learning for a total of 10 hours. These findings provide support for introducing interventions for somatosensory impairment in rehabilitation programs for patients with stroke.
Implications for Research
This review has highlighted the need to use reliable and valid measures of somatosensory functions in research. Additionally, more standardized somatosensory measures, such as the perceptual threshold of touch, 38 need to be investigated to determine the predictive value on outcome after stroke. Furthermore, important gaps in the current knowledge need to be addressed. First, this review showed a large range in strength of the relationship between somatosensory and motor or functional outcome after stroke. Larger, high-quality cohort studies combining neurophysiological and clinical somatosensory measures of different modalities are needed to determine this relationship with more accuracy. Second, the relationship between the lesion location and extent of the stroke with somatosensory impairments needs to be further explored, as this information will increase our insights into the neural correlates of somatosensory processing. Third, the quality assessment of observational studies needs to be standardized, and validity needs to be established. Finally, insights are lacking regarding the extent of deficits in different somatosensory modalities and the recovery patterns of the different somatosensory modalities after stroke. These insights are crucial in guiding and delineating treatment interventions for somatosensory deficits in patients with stroke.
